The deadline for all submissions is 28 January 2022 (23:59 GMT+1).
Abstracts will be accepted in English only
Encore Abstracts will not be accepted
An international panel of reviewers will review all abstracts anonymously
Abstracts can only be submitted online, via the submission portal. Paper, eMail submission and USB/CD submission will NOT be accepted.
Submitting an abstract does not register you for ICNMD2022; You must register for the Congress.
ICNMD2022 organizers expect that all abstracts selected for presentation will be presented by the authors and that submitted abstracts will not be withdrawn.
Please do not submit an abstract if you are not able to travel to the Congress and present it in the form selected.
Case reports presented as abstract for poster display are accepted.
All authors must complete a conflict of interest on their abstract submission.
If your research has been granted any commercial or institutional support, you will be asked to disclose this during the submission process.
Posters by representatives of commercial companies are accepted with the authors’ names (and any professional designation such as MD, or Researcher etc.) only, and are not to include names or associations with the commercial companies that they represent. Generic product names may be used but not company product names.
Please note, all abstracts are submitted as a poster presentation and the posters with the top scores will be invited to present their work in one of the sessions at ICNMD 2022.
Topic Group 1 - Muscle Diseases. Genetic and Acquired Myopathies: Clinical Features, Pathophysiology, Therapy
Inflammatory / Immune-mediated Myopathies/Inclusion Body Myopathies: sIBM,